Association of olfactory dysfunction in chronic rhinosinusitis with economic productivity and medication usage

Rodney J. Schlosser, Kristina A. Storck, Luke Rudmik, Timothy Smith, Jess C. Mace, Jose Mattos, Zachary M. Soler

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Chronic rhinosinusitis (CRS) has significant impacts upon productivity, economic metrics, and medication usage; however, factors that are associated with these economic outcomes are unknown. Methods: We evaluated olfactory dysfunction in 221 patients with CRS using the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) and the 40-item Smell Identification Test (SIT) and assessed whether an association existed between these olfactory metrics and healthcare utilization, productivity, and medication usage over the preceding 90 days. Results: After adjusting for CRS-associated comorbidities, objective measures of disease, demographics, and CRS-specific quality of life (QOL), patients with lower QOD-NS scores (worse patient-reported olfaction) had more missed days of normal productivity and employment, worse productivity levels, more hours of missed employment due to physician visits, more time caring for sinuses, greater distance traveled to medical appointment, more days of oral steroid use, and higher odds of being on disability insurance. Clinical olfaction, as measured by SIT, was associated with greater distance traveled to medical appointment and higher odds of being on disability insurance, but did not correlate with other productivity measures. Conclusion: Impaired olfactory-specific QOL is associated with significantly worse economic and productivity metrics and increased medication usage even after adjusting for CRS-specific comorbidities, objective measures of disease, demographics, and severity of CRS-specific QOL. Future studies are warranted to determine if targeting the impaired olfactory-specific QOL noted in patients with CRS results in improved productivity and economic outcomes.

Original languageEnglish (US)
JournalInternational Forum of Allergy and Rhinology
DOIs
StateAccepted/In press - 2016

Fingerprint

Smell
Disability Insurance
Economics
Quality of Life
Comorbidity
Appointments and Schedules
Demography
Chronic Disease
Steroids
Delivery of Health Care
Physicians
Identification (Psychology)
Surveys and Questionnaires

Keywords

  • Chronic rhinosinusitis
  • Olfaction
  • Olfactory test
  • Productivity
  • Quality of life

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Association of olfactory dysfunction in chronic rhinosinusitis with economic productivity and medication usage. / Schlosser, Rodney J.; Storck, Kristina A.; Rudmik, Luke; Smith, Timothy; Mace, Jess C.; Mattos, Jose; Soler, Zachary M.

In: International Forum of Allergy and Rhinology, 2016.

Research output: Contribution to journalArticle

Schlosser, Rodney J. ; Storck, Kristina A. ; Rudmik, Luke ; Smith, Timothy ; Mace, Jess C. ; Mattos, Jose ; Soler, Zachary M. / Association of olfactory dysfunction in chronic rhinosinusitis with economic productivity and medication usage. In: International Forum of Allergy and Rhinology. 2016.
@article{90e7dbc1afb847b6a1cf14cd24a0235e,
title = "Association of olfactory dysfunction in chronic rhinosinusitis with economic productivity and medication usage",
abstract = "Background: Chronic rhinosinusitis (CRS) has significant impacts upon productivity, economic metrics, and medication usage; however, factors that are associated with these economic outcomes are unknown. Methods: We evaluated olfactory dysfunction in 221 patients with CRS using the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) and the 40-item Smell Identification Test (SIT) and assessed whether an association existed between these olfactory metrics and healthcare utilization, productivity, and medication usage over the preceding 90 days. Results: After adjusting for CRS-associated comorbidities, objective measures of disease, demographics, and CRS-specific quality of life (QOL), patients with lower QOD-NS scores (worse patient-reported olfaction) had more missed days of normal productivity and employment, worse productivity levels, more hours of missed employment due to physician visits, more time caring for sinuses, greater distance traveled to medical appointment, more days of oral steroid use, and higher odds of being on disability insurance. Clinical olfaction, as measured by SIT, was associated with greater distance traveled to medical appointment and higher odds of being on disability insurance, but did not correlate with other productivity measures. Conclusion: Impaired olfactory-specific QOL is associated with significantly worse economic and productivity metrics and increased medication usage even after adjusting for CRS-specific comorbidities, objective measures of disease, demographics, and severity of CRS-specific QOL. Future studies are warranted to determine if targeting the impaired olfactory-specific QOL noted in patients with CRS results in improved productivity and economic outcomes.",
keywords = "Chronic rhinosinusitis, Olfaction, Olfactory test, Productivity, Quality of life",
author = "Schlosser, {Rodney J.} and Storck, {Kristina A.} and Luke Rudmik and Timothy Smith and Mace, {Jess C.} and Jose Mattos and Soler, {Zachary M.}",
year = "2016",
doi = "10.1002/alr.21841",
language = "English (US)",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Association of olfactory dysfunction in chronic rhinosinusitis with economic productivity and medication usage

AU - Schlosser, Rodney J.

AU - Storck, Kristina A.

AU - Rudmik, Luke

AU - Smith, Timothy

AU - Mace, Jess C.

AU - Mattos, Jose

AU - Soler, Zachary M.

PY - 2016

Y1 - 2016

N2 - Background: Chronic rhinosinusitis (CRS) has significant impacts upon productivity, economic metrics, and medication usage; however, factors that are associated with these economic outcomes are unknown. Methods: We evaluated olfactory dysfunction in 221 patients with CRS using the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) and the 40-item Smell Identification Test (SIT) and assessed whether an association existed between these olfactory metrics and healthcare utilization, productivity, and medication usage over the preceding 90 days. Results: After adjusting for CRS-associated comorbidities, objective measures of disease, demographics, and CRS-specific quality of life (QOL), patients with lower QOD-NS scores (worse patient-reported olfaction) had more missed days of normal productivity and employment, worse productivity levels, more hours of missed employment due to physician visits, more time caring for sinuses, greater distance traveled to medical appointment, more days of oral steroid use, and higher odds of being on disability insurance. Clinical olfaction, as measured by SIT, was associated with greater distance traveled to medical appointment and higher odds of being on disability insurance, but did not correlate with other productivity measures. Conclusion: Impaired olfactory-specific QOL is associated with significantly worse economic and productivity metrics and increased medication usage even after adjusting for CRS-specific comorbidities, objective measures of disease, demographics, and severity of CRS-specific QOL. Future studies are warranted to determine if targeting the impaired olfactory-specific QOL noted in patients with CRS results in improved productivity and economic outcomes.

AB - Background: Chronic rhinosinusitis (CRS) has significant impacts upon productivity, economic metrics, and medication usage; however, factors that are associated with these economic outcomes are unknown. Methods: We evaluated olfactory dysfunction in 221 patients with CRS using the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) and the 40-item Smell Identification Test (SIT) and assessed whether an association existed between these olfactory metrics and healthcare utilization, productivity, and medication usage over the preceding 90 days. Results: After adjusting for CRS-associated comorbidities, objective measures of disease, demographics, and CRS-specific quality of life (QOL), patients with lower QOD-NS scores (worse patient-reported olfaction) had more missed days of normal productivity and employment, worse productivity levels, more hours of missed employment due to physician visits, more time caring for sinuses, greater distance traveled to medical appointment, more days of oral steroid use, and higher odds of being on disability insurance. Clinical olfaction, as measured by SIT, was associated with greater distance traveled to medical appointment and higher odds of being on disability insurance, but did not correlate with other productivity measures. Conclusion: Impaired olfactory-specific QOL is associated with significantly worse economic and productivity metrics and increased medication usage even after adjusting for CRS-specific comorbidities, objective measures of disease, demographics, and severity of CRS-specific QOL. Future studies are warranted to determine if targeting the impaired olfactory-specific QOL noted in patients with CRS results in improved productivity and economic outcomes.

KW - Chronic rhinosinusitis

KW - Olfaction

KW - Olfactory test

KW - Productivity

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84992460250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992460250&partnerID=8YFLogxK

U2 - 10.1002/alr.21841

DO - 10.1002/alr.21841

M3 - Article

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

ER -